Back to Authors

Merrell, Ryan

https://orcid.org/0000-0002-8076-0768

Mayo Clinic

Vanderbilt University Medical Center

Citations 12

History of chickenpox in glioma risk: a report from the glioma international case–control study (GICC)
Amirian, E. Susan , Scheurer, Michael E. , Zhou, Renke, Wrensch, Margaret , Armstrong, Georgina , Olson, Sara H. , Claus, Elizabeth B. , Barnholtz‐Sloan, Jill S. , Schildkraut, Joellen M. , Ali‐Osman, Francis, Sadetzki, Siegal , Jenkins, Robert B. , Bernstein, Jonine L. , Merrell, Ryan , Davis, Faith G., Lai, Rose , Shete, Sanjay , Melin, Beatrice , Bondy, Melissa L. , Lachance, Daniel, Armstrong, Georgina , Lachance, Daniel Honore , Lau, Ching C. , Il’yasova, Dora , Amos, Christopher I. , Barnholtz-Sloan, Jill S

Cancer Medicine | March 14, 2016 | Volume: 5 | Issue: 6 | Pages: 1352-1358

10.1002/cam4.682 Get It

AbstractVaricella zoster virus (VZV) is a neurotropic α‐herpesvirus that causes chickenpox and establishes life‐long latency in the cranial nerve and dorsal root ganglia of the host. To date, VZV is the only virus consistently reported to have an inverse association with glioma. The Glioma International Case‐Control Study (GICC) is a large, multisite consortium with data on 4533 cases and 4171 controls collected across five countries. Here, we utilized the GICC data to confirm the previously reported associations between history of chickenpox and glioma risk in one of the largest studies to date on this topic. Using two‐stage random‐effects restricted maximum likelihood modeling, we found that a positive history of chickenpox was associated with a 21% lower glioma risk, adjusting for age and sex (95% confidence intervals (CI): 0.65–0.96). Furthermore, the protective effect of chickenpox was stronger for high‐grade gliomas. Our study provides additional evidence that the observed protective effect of chickenpox against glioma is unlikely to be coincidental. Future studies, including meta‐analyses of the literature and investigations of the potential biological mechanism, are warranted.
Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study
Amirian, E. Susan , Zhou, Renke, Wrensch, Margaret , Olson, Sara H. , Scheurer, Michael E. , Armstrong, Georgina , McCoy, Lucie , Lau, Ching C., Claus, Elizabeth B. , Barnholtz‐Sloan, Jill S. , Schildkraut, Joellen M. , Ali‐Osman, Francis, Sadetzki, Siegal , Johansen, Christoffer , Houlston, Richard S. , Jenkins, Robert B. , Bernstein, Jonine L. , Merrell, Ryan , Davis, Faith G., Lai, Rose , Shete, Sanjay , Melin, Beatrice , Bondy, Melissa L. , Lachance, Daniel, Il’yasova, Dora , Lachance, Daniel Honore , Armstrong, Georgina , Amos, Christopher I. , Houlston, Richard S , Barnholtz-Sloan, Jill S

Cancer Epidemiology, Biomarkers & Prevention | February 5, 2016 | Volume: 25 | Issue: 2 | Pages: 282-290

10.1158/1055-9965.epi-15-0847 Get It

Abstract Background: Several previous studies have found inverse associations between glioma susceptibility and a history of allergies or other atopic conditions. Some evidence indicates that respiratory allergies are likely to be particularly relevant with regard to glioma risk. Using data from the Glioma International Case-Control Study (GICC), we examined the effects of respiratory allergies and other atopic conditions on glioma risk. Methods: The GICC contains detailed information on history of atopic conditions for 4,533 cases and 4,171 controls, recruited from 14 study sites across five countries. Using two-stage random-effects restricted maximum likelihood modeling to calculate meta-analysis ORs, we examined the associations between glioma and allergy status, respiratory allergy status, asthma, and eczema. Results: Having a history of respiratory allergies was associated with an approximately 30% lower glioma risk, compared with not having respiratory allergies (mOR, 0.72; 95% confidence interval, 0.58–0.90). This association was similar when restricting to high-grade glioma cases. Asthma and eczema were also significantly protective against glioma. Conclusion: A substantial amount of data on the inverse association between atopic conditions and glioma has accumulated, and findings from the GICC study further strengthen the existing evidence that the relationship between atopy and glioma is unlikely to be coincidental. Impact: As the literature approaches a consensus on the impact of allergies in glioma risk, future research can begin to shift focus to what the underlying biologic mechanism behind this association may be, which could, in turn, yield new opportunities for immunotherapy or cancer prevention. Cancer Epidemiol Biomarkers Prev; 25(2); 282–90. ©2016 AACR.